← Back to headlines
Mineralys Therapeutics (MLYS) Advances with FDA for Hypertension Drug
Mineralys Therapeutics (MLYS) is making progress with the FDA regarding its drug for hypertension.
13 Mar, 18:52 — 13 Mar, 18:52
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Four Arrested for Selling P102 Million in Counterfeit Anti-Cancer Medicine in Makati
just now
Philippines receives diesel shipment from Malaysia
just now
Bulgaria Issues 12,000 Permits for Foreign Tourism Workers in Three Months
20m ago